P. Wang

Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.

N. Zhao, A. Stoffel, P. Wang, 1997, Proceedings of the National Academy of Sciences of the United States of America.

dic(5;17): A recurring abnormality in malignant myeloid disorders associated with mutations of TP53

N. Zhao, P. Wang, R. Larson, 1997, Genes, chromosomes & cancer.

Human KRML (MAFB): cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias.

G. Barsh, M. Stoffel, P. Wang, 1999, Genomics.

Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.

P. Wang, J. Eisenbart, R. Espinosa, 2000, Genomics.

Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias.

N. Zhao, P. Wang, J. Eisenbart, 1998, Genomics.

Clinical and molecular response of AML harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors

P. Wang, R. Larson, W. Stock, 2022, medRxiv.

Statistical Analysis of Pulsar Flux Density Distribution

P. Wang, Z. Tu, C. Miao, 2024, The Astrophysical Journal.